InvestorsHub Logo
Followers 9
Posts 4042
Boards Moderated 0
Alias Born 03/20/2001

Re: None

Monday, 04/20/2015 11:05:43 PM

Monday, April 20, 2015 11:05:43 PM

Post# of 396
Here comes new shares.... ?

Tue 21 Apr 2015 13:14 AAP – 1 hour 8 minutes ago

https://au.finance.yahoo.com/news/novogen-taps-investors-30-5m-015812296.html

Is this what others have said happens with NVGN... up goes the price on multiple PRs, add new shares into the pot.... repeat? I have only watched NVGN for a short time and only read a handful of posts... so it's really an honest question.

Is this a repeat of history for those who have been involved for 6-12+ months?

Here is the PR:

Novogen is tapping investors for $30.5 million as it prepares to enter a major growth phase fuelled by development of its cancer-fighting drugs.

The biotech is carrying out a $15.5 million share placement with institutional investors and issuing another $15 million worth of shares to existing shareholders.

Chief executive Graham Kelly says Novogen will use the money raised to help pay for research programs into the development of the company's drug pipeline.

"The company is about to enter a significant growth phase," he said in a statement on Tuesday.

"I believe that the company has the intellectual property and the management expertise to achieve its goal of becoming a major player in the international biotechnology sector, and the fund-raising that we have announced today is key to that."

As part of its fundraising, Novogen is issuing 51 million fully-paid ordinary shares with attaching options to institutional investors in the United States.

Existing shareholders will also be able to take part in a one-for-six non-renounceable rights issue offer of fully-paid ordinary shares.

Novogen shares were 12.5 per cent, or 30 per cent, lower at 29 cents at 1152 AEST.